Evidence map›Paper›PMID 39732968›Full record

ArticleScientific reports2024

Caftaric acid attenuates kidney and remote organ damage induced by renal ischemia-reperfusion injury.

Fazile Nur Ekinci Akdemir, Mustafa Can Güler, Ersen Eraslan, Ayhan Tanyeli, Serkan Yildirim

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fazile Nur Ekinci AkdemirDepartment of Nutrition and Dietetics, Faculty of Health Science, Ağrı İbrahim Çeçen University, Ağrı, Turkey.
Mustafa Can GülerDepartment of Physiology, Faculty of Medicine, Atatürk University, Erzurum, 25240, Turkey.
Ersen EraslanDepartment of Physiology, Faculty of Medicine, Bandırma OnYedi Eylül University, Balıkesir, Turkey.
Ayhan TanyeliDepartment of Physiology, Faculty of Medicine, Atatürk University, Erzurum, 25240, Turkey. ayhan.tanyeli@atauni.edu.tr.ORCID 0000-0002-0095-0917
Serkan YildirimDepartment of Pathology, Faculty of Veterinary, Atatürk University, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress and inflammation are indispensable components of ischemia-reperfusion (IR) injury. In this study, we investigated the effects of low and high doses of caftaric acid (CA) on reducing kidney and remote organ damage induced by IR. We divided Wistar rats into four groups: sham, IR, low (40 mg/kg body weight (BW)), and high (80 mg/kg BW) CA groups. IR (1 h ischemia, 24 h reperfusion) was applied to all groups, except the sham one. Following the experimental period, we removed kidney and lung tissues to assess biochemical, histopathological, and immunohistochemical parameters. In the IR group, oxidant parameters (malondialdehyde (MDA), myeloperoxidase (MPO), total oxidant status (TOS), oxidative stress index (OSI)) increased, and antioxidant level parameters (superoxide dismutase (SOD) and total antioxidant status (TAS)) diminished. In addition, Microtubule-associated protein light chain 3 (LC3), cyclooxygenase-2 (COX-2), and caspase-3 immunopositivity were severe in the IR group. CA treatment improved the LC3, COX-2, and caspase-3 immunopositivity, lowered the oxidant level, and enhanced the antioxidant capacity. Histopathological findings were consistent with the data. In light of all our results, CA is effective against oxidative stress, autophagy, apoptosis, and inflammation in the renal IR experimental model.

Indexed as

AntioxidantsKidneyOxidative StressRats, WistarReperfusion InjuryAnimalsApoptosisLungMaleRatsAntioxidantsAcute kidney injuryApoptosisAutophagyCaftaric acidIschemia-reperfusionLungOxidative stress

Identifiers

PMID39732968
PMCPMC11682263

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.